Clinical Trial Update: Aprotinin US Special Access Protocol

View source ↗

Summary

The US Special Access Protocol for aprotinin (Trasylol) has been withdrawn/no longer available, per sponsor Bayer, affecting access for postoperative hemorrhage…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Hemorrhage

Drugs mentioned

• Trasylol (aprotinin)

Snippet

Sponsor: Bayer | Conditions: Postoperative Hemorrhage | Status: NO_LONGER_AVAILABLE